UNITED STATES IN-VITRO FERTILIZATION (IVF) DEVICES MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2025

In this report, the United States In-Vitro Fertilization (IVF) Devices Market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.

In-Vitro Fertilization (IVF) is an advanced medical procedure that involves the combination of surgical procedures and medicines to help in the implantation of eggs in the uterus. This procedure is basically performed on the women that cannot have a normal pregnancy. In this procedure eggs are infused with sperm outside the uterus in an artificial environment - this procedure is also called insemination where sperms and eggs are stored in a special container to promote the fertilization of eggs. After a few days, the fertilized egg is implanted into the womb of women which is called embryo transfer.

Growing cases of infertility cases in the U.S. country is primarily fueling the market growth of In-Vitro Fertilization (IVF) devices. According to the Centers for Disease Control and Prevention (CDC), about 10 percent of women (6.1 million) in the United States ages 15-44 have difficulty getting pregnant or staying pregnant. Moreover, the growing focus of manufacturers to introduce advanced in-vitro fertilization devices is further anticipated to foster market growth. For instance, in July 2018, Merck, a leading science and technology company, announced the launch of QBOX IVF, and the new Geri® Assess 2.0, in its continued drive to serve the needs of its customers and to become the preferred treatment partner for all IVF stakeholders and assisted reproductive treatment (ART) clinics.

Key Developments:

• In January 2019, Ferring Pharmaceuticals has agreed on terms to acquire the US commercialization rights for a generic version of ganirelix acetate, an injectable therapy used to prevent premature luteinizing hormone surges in women undergoing fertility treatment.
• In November 2016, Merck has introduced two fertility technologies, Gidget and Geri+ to extend its portfolio to support all steps performed by fertility laboratories during assisted reproductive treatment.
• In April 2018, the Cooper Companies, Inc., announced that CooperSurgical has acquired the assets of The LifeGlobal Group and its affiliates, a provider of in-vitro fertilization (IVF) devices. The transaction is valued at approximately $125 million and is expected to be neutral to earnings per share in fiscal 2018 and accretive thereafter, excluding one-time charges and deal-related amortization.
• In October 2016, Merck KGaA’s North American unit established a Fertility Technologies division with the launch of its hand-held witnessing device for the facilitation of in vitro fertilization procedures. EMD Serono is the German company’s biopharmaceutical business in the U.S. and Canada.
• In March 2019, INVO Bioscience, Inc, developers of the INVOcell intravaginal culture (IVC) system, today announced the launch of its first Company-owned embryology center in the Bay Area of California.

Geographically, this report splits the United States market into seven regions:
✒ The West
✒ Southwest
✒ The Middle Atlantic
✒ New England
✒ The South
✒ The Midwest
with sales (volume), revenue (value), market share and growth rate of In-Vitro Fertilization (IVF) Devices in these regions, from 2014 to 2025 (forecast).

United States In-Vitro Fertilization (IVF) Devices market competition by top manufacturers/players, with In-Vitro Fertilization (IVF) Devices sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
✒ Esco
✒ Memmert
✒ Hamilton
✒ Vitrolife
✒ EurimPharm
✒ SunIVF
✒ Origio Humagen
✒ COOK
✒ Nidacon
✒ Meditex
✒ Nuode Medical
✒ Hema

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
✒ Intracytoplasmic Sperm Injection (ICSI)
✒ Frozen Embryo Replacement (FER)
✒ Pre-implantation Genetic Diagnosis (PGD)

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of In-Vitro Fertilization (IVF) Devices for each application, including
✒ Clone
✒ Transgenic
✒ Embryonic Stem Cell Isolation and Culture
✒ Test Tube Baby

**NOTE: If you have any special requirements, please let us know and we will offer you the report as you want.